Rosetta Genomics Ltd. (ROSG) [Rocket]

Overview

Rosetta Genomics Ltd. (ROSG)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Recent News + Filings (All items)

Date Filed	Type	Description
04/22/2019	4	SABBY MANAGEMENT, LLC (10% Owner) has filed a Form 4 on Rosetta Genomics Ltd.
01/04/2019	SC 13G/A	SABBY MANAGEMENT, LLC reports a 15.9% stake in Rosetta Genomics Ltd
07/19/2018	25-NSE	Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
06/07/2018	SC 13G/A	MORGAN STANLEY reports a 0% stake in Rosetta Genomics Ltd.
05/18/2018	6-K	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
05/01/2018	NT 20-F	Form NT 20-F - Notification of inability to timely file Form 20-F:
04/27/2018	6-K	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-16	Dec-31-15	Dec-31-14	Dec-31-13	Dec-31-12	Dec-31-11	Dec-31-10	Dec-31-09
Revenues	9.2	8.3	1.3	0.4	0.2	0.1	0.3	0.2
Revenue growth	11.7%	523.1%	227.7%	101.5%	95.1%	-63.1%	86.0%
Cost of goods sold	7.4	6.3	1.3	0.7	0.3	0.3	0.6	0.3
Gross profit	1.8	2.0	0.0	-0.3	-0.1	-0.2	-0.3	-0.2
Gross margin	19.4%	24.1%	1.3%	-75.1%	-28.4%	-214.6%	-125.1%	-126.0%
Sales and marketing	6.8	7.4	6.8	7.0	3.9	2.6	4.9	4.5
Research and development	3.2	3.0	1.9	1.7	1.2	3.4	5.7	6.6
General and administrative	7.5	7.6	5.5	4.3	3.0	2.5	2.4	3.6
EBIT	15.7	15.7	14.3	13.3	8.3	8.8	13.9	14.8
EBIT margin	169.6%	190.1%	1074.0%	3295.6%	4112.9%	8521.4%	4987.5%	9864.7%
Pre-tax income	16.3	17.3	14.5	13.2	10.7	7.4	13.0	14.8
Income taxes	0.0	0.0	0.0	0.3	0.2	5.9	11.1	-1.8
Tax rate	0.2%			2.1%	2.2%	80.5%	85.6%
Earnings from continuing ops	16.2	17.3	14.5	13.4	10.9	7.4	13.3	14.8
Earnings from discontinued ops				-0.3	-0.2	1.4	1.9
Net income	16.2	17.3	14.5	13.2	10.7	8.8	15.1	16.5
Net margin	175.8%	209.8%	1094.6%	3251.9%	5321.4%	8572.8%	5427.2%	11003.3%

Diluted EPS	$9.31	$13.79	$15.51	$1.40	$2.46	$14.55	$45.88	$4.36
Shares outstanding (diluted)	1.7	1.3	0.9	9.6	4.4	0.5	0.3	3.4

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.